Corporate calendar for AN2 Therapeutics, Inc. (ANTX): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
AN2 Therapeutics, Inc. is a biopharmaceutical company currently in its clinical development phase, specializing in the creation of treatments for uncommon, long-term, and severe infectious conditions. A key focus of their pipeline is epetraborole, an investigational oral medication designed for once-daily administration to individuals battling chronic non-tuberculous mycobacterial lung disease.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-14 | ||
| 2026-09-14 | ||
| 2026-09-14 | ||
| 2026-09-14 | ||
| 2026-09-14 | $-0.05 | $8M |
| 2026-09-14 |
Dividend History
| Date | Amount | Yield |
|---|---|---|
| 2018-01-11 | $0.6562 | 49.16% |
| 2017-10-12 | $0.6562 | 49.16% |
| 2017-07-12 | $0.6562 | 49.16% |
| 2017-04-11 | $0.6562 | 49.16% |
| 2017-01-11 | $0.6562 | 49.16% |
| 2016-10-12 | $0.6562 | 49.16% |
| 2016-07-13 | $0.6562 | 49.16% |
| 2016-04-13 | $0.6562 | 49.16% |
| 2016-01-13 | $0.6562 | 49.16% |
| 2015-10-13 | $0.6562 | 49.16% |
Price
| Price | $5.34 |
| Market Cap | $192M |
| Exchange | NASDAQ |
| Country | US |
Related companies: BOLD · IBIO · INTS · ITRM · NXTC · PLUR · PSTV
Explore sector: Healthcare · Biotechnology
More sections of ANTX: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks